Kevin Ackhurst

Subscribe to all posts by Kevin Ackhurst

Competition Bureau issues statement regarding off-label use of vaccines

Photo of Kevin AckhurstPhoto of Richard WagnerPhoto of David YiPhoto of Pharma in Brief teamBy Kevin Ackhurst, Richard Wagner, David Yi and Pharma in Brief team on Posted in Life sciences and healthcare, Pharmaceuticals and life sciences
The Competition Bureau (Bureau) recently conducted a preliminary investigation into possible competition concerns arising from a proposal to include a clause in a procurement contract that would restrict off-label use of a vaccine.  The Bureau concluded that there was no abuse of dominance as the provision was not included in the procurement contract; however, it … Continue reading

Getting the Deal Through – Pharmaceutical Antitrust

Photo of Kevin AckhurstBy Kevin Ackhurst on Posted in Pharmaceuticals and life sciences
Norton Rose Fulbright has published a new edition of Getting the Deal Through – Pharmaceutical Antitrust. This edition is an updated, thorough overview of the application of antitrust law to the pharmaceutical sector worldwide. The pharmaceutical sector remains a priority area for antitrust enforcement in most major jurisdictions, where enforcement agencies have been increasingly prone … Continue reading
LexBlog